Skip to main content
Premium Trial:

Request an Annual Quote

French Proteomics Co. to Develop New Protein Biochip

NEW YORK, Nov 27 – French Proteomics company Proteus and CEA-LETI, part of the French Agency for Atomic Energy have announced a partnership to develop biochips for proteomic analysis, Proteus announced Nov 23.

The chip will use phenomics, a proprietary technology that allows researchers to access the entire proteome from a given genome or fragments of it. The process sorts each protein and maintains its function, preserving access to the corresponding genetic information, according to Proteus.

Currently, Proteus markets the phenomics technology in the form of a 96-well microteterplate. The new partnership will convert the technology into a group of over 8000 3cm microwell biochips. CEA-LETI, based in Grenoble, France, has already developed prototypes of electronic chips suited for molecular biology applications.

The French government is providing funding to the partnership through its post genomic-sequencing program.
The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.